End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 EUR | -.--% | -.--% | -.--% |
06-17 | Neovacs: collaboration agreement with CNRS | CF |
06-10 | Neovacs: presents results from vaccine candidates | CF |
Sales 2022 | 1.11K 1.19K 1.63K | Sales 2023 | 533K 571K 782K | Capitalization | 278 297.76 407.61 |
---|---|---|---|---|---|
Net income 2022 | -3M -3.21M -4.4M | Net income 2023 | -8M -8.57M -11.73M | EV / Sales 2022 | - |
Net cash position 2022 | 5.55M 5.95M 8.14M | Net cash position 2023 | 237K 253K 347K | EV / Sales 2023 | -0.44 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0.12% |
3 months | -99.04% |
Managers | Title | Age | Since |
---|---|---|---|
Hugo Brugière
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | - | 20-09-30 | |
Vincent Serra
COO | Chief Operating Officer | 55 | 19-02-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 85 | 03-05-27 | |
Daniel Zagury
FOU | Founder | - | 93-04-15 |
Hugo Brugière
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+20.42% | 46.93B | |
+37.69% | 39.08B | |
-8.20% | 38.48B | |
+29.57% | 31.01B | |
-12.26% | 26.14B | |
+10.88% | 25.88B | |
+35.33% | 12.53B | |
-6.77% | 11.36B | |
-12.42% | 10.65B |
- Stock Market
- Equities
- ALNEV Stock
- 0LW Stock